loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Open ICICI
3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

+91

BLOG

Misses - BFSI

ICICIdirect Research 23 Oct 2026 DISCLAIMER

Shriram Finance(CMP – Rs 868, Reco – Buy)

Shriram Finance reported healthy performance in Q2FY27. AUM grew 17% YoY to ₹3.29 lakh crore, supported by healthy traction in gold, MSME and personal loans. Substantial uptick of 48 bps QoQ was witnessed in margins to 9.52%, aided by deployment of equity capital raised from MUFG. Controlled opex supported earnings momentum, with PAT growing 59.4% YoY. Despite healthy performance, drought-related stress and geopolitical uncertainty could lead to moderation in growth and deterioration in asset quality, and thus remain key concerns, thereby impacting valuations.

Nippon Life India AMC(CMP – Rs 925, Reco – Buy)

NAM reported healthy performance as AUM market share broadly remained flat at 9.02%. Revenue was at ₹796 crore (up 21% YoY, 4% QoQ). Core operating profit was reported at ₹523 crore (+25% YoY, 6% QoQ). PAT reported at ~₹324 crore (-6% YoY, -36% QoQ), impacted by lower other income at ~₹23 crore and exceptional expenses of ~₹97 crore. Sustained traction in systematic flows, leadership in ETFs and higher retail presence should support AUM growth, while operating leverage remains supportive of core earnings. NAM remains well placed to benefit from structural financialization of savings.

 

 

Download
ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere

Download
ICICI Direct app

Invest, Track, and Manage your Portfolio Anytime, Anywhere